Additionally, increased (not significant) numbers of CD19+CD5+ and CD19+CD5+CD1d+ B cells were detected in the livers of mice with MASLD (Fig. S6A–C). This evidence concerns the gene CD19 and metabolic dysfunction-associated steatotic liver disease.